The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Hyperglycemia in Acute Ischemic Stroke: A Vascular Perspective
Abstract
Admission hyperglycemia complicates approximately one-third of acute ischemic strokes and is associated with a worse clinical outcome. Both human and animal studies have showed that hyperglycemia is particularly detrimental in ischemia/reperfusion. Decreased reperfusion blood flow has been observed after middle cerebral artery occlusion in acutely hyperglycemic animals, suggesting the vasculature as an important site of hyperglycemic reperfusion injury. This paper reviews biochemical and molecular pathways in the vasculature that are rapidly affected by hyperglycemia and concludes that these changes result in a pro-vasoconstrictive, pro-thrombotic and pro-inflammatory phenotype that renders the vasculature vulnerable to reperfusion injury. Understanding these pathways should lead to the development of rational therapies that reduce hyperglycemic reperfusion injury and thus improve outcome in this large subset of acute ischemic stroke patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957 · cited 3×
“Loss of NO bioavailability has been found under a number of pathological conditions, including hyperglycemia (Forstermann and Munzel, 2006).”
BackgroundInfluentialCapes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824 · cited 4×
“Meta-analysis revealed a more than three-fold increase in 30-day mortality for nondiabetic hyperglycemics, compared with a two-fold increase for diabetic patients who were hyperglycemic on admission (Capes et al, 2001).”
BackgroundResultInfluentialLandmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092 · cited 1×
“Glucagon-like peptide 1 is strictly glucose dependent, so it does not continue to decrease blood glucose once normoglycemia is attained (Nauck et al, 1993).”
BackgroundS-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death
Gu, Z., Kaul, M., Yan, B., Kridel, S. J., Cui, J., Strongin, A., Smith, J. W., Liddington, R. C., & Lipton, S. A. (2002) · Science · doi:10.1126/science.1073634 · Cited by 950
Du, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907 · cited 5×
“Although the time course of these effects has only been studied at 48 to 96 h (Chen et al, 1998; Du et al, 2000, 2001; Federici et al, 2002; Goldberg et al, 2002), hyperglycemia produces dramatically increased levels of the hexosamine pathway end product UDP-N-acetylglucosamine in as little as 1 h…”
BackgroundInfluentialNikolaidis, L. A., Mankad, S., Sokos, G. G., Miske, G., Shah, A., Elahi, D., & Shannon, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000120505.91348.58 · Cited by 901 · cited 1×
“Similarly, a small pilot study found that GLP-1 infusion improved left ventricular function in both diabetic and non-diabetic patients after myocardial ischemia/reperfusion (Nikolaidis et al., 2004).”
Background
Cited by
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352
Self-citationHyperglycemia in acute ischemic stroke: pathophysiology and clinical management
Kruyt, N. D., Biessels, G. J., DeVries, J. H., & Roos, Y. B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.231 · Cited by 386
Glucose and NADPH oxidase drive neuronal superoxide formation in stroke
Suh, S. W., Shin, B. S., Ma, H., Van Hoecke, M., Brennan, A. M., Yenari, M. A., & Swanson, R. A. (2008) · Annals of Neurology · doi:10.1002/ana.21511 · Cited by 292
Bioenergetic regulation of microglia
Ghosh, S., Castillo, E., Frias, E. S., & Swanson, R. A. (2018) · Glia · doi:10.1002/glia.23271 · Cited by 291
Ergul, A., Elgebaly, M. M., Middlemore, M.-L., Li, W., Elewa, H., Switzer, J. A., Hall, C., Kozak, A., & Fagan, S. C. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-33 · Cited by 113
“Numerous studies including the NINDS tPA stroke trial showed that elevated admission blood sugar was a significant predictor of poor clinical outcome and HT [16-18].”
BackgroundChen, J., Ning, R., Zacharek, A., Cui, C., Cui, X., Yan, T., Venkat, P., Zhang, Y., & Chopp, M. (2016) · Stem Cells · doi:10.1002/stem.2193 · Cited by 58
Neuroprotective effect of asiatic acid in rat model of focal embolic stroke
Lee, K. Y., Bae, O.-N., Weinstock, S., Kassab, M., & Majid, A. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00055 · Cited by 31
Metadata
- Authors
- Martini, S. R., & Kent, T. A.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2007-03
- Volume
- 27
- Issue
- 3
- Pages
- 435-451
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2023654874
- Cited by
- 240
- References
- 19
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.